Prio Wealth Limited Partnership’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Prio Wealth Limited Partnership’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,646	Closed	-$238K	–	265
2022 Q1	$238K	Hold	2,646	–	–	0.01%	246
2021 Q4	$296K	Sell	2,646 -400	-13%	-$48.2K	0.01%	238
2021 Q3	$383K	Hold	3,046	–	–	0.01%	216
2021 Q2	$412K	Hold	3,046	–	–	0.01%	210
2021 Q1	$413K	Sell	3,046 -450	-13%	-$67.4K	0.01%	204
2020 Q4	$492K	Buy	3,496 +639	+22%	+$81.8K	0.02%	186
2020 Q3	$318K	Hold	2,857	–	–	0.01%	209
2020 Q2	$320K	Buy	+2,857	New	+$281K	0.01%	202
2020 Q1	–	Sell	-2,407	Closed	-$229K	–	256
2019 Q4	$229K	Sell	2,407 -300	-11%	-$25.9K	0.01%	243
2019 Q3	$206K	Buy	+2,707	New	+$225K	0.01%	247
2014 Q1	–	Sell	-11,580	Closed	-$502K	–	260
2013 Q4	$502K	Hold	11,580	–	–	0.03%	178
2013 Q3	$498K	Hold	11,580	–	–	0.03%	177
2013 Q2	$402K	Buy	+11,580	New	+$407K	0.02%	183

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Prio Wealth Limited Partnership's XBI Position: Q2 2022 in Review

Prio Wealth Limited Partnership sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,646 shares — an estimated $238K sold.

Prio Wealth Limited Partnership first reported a position in XBI in Q2 2013 and held it in 13 quarters. The position peaked at $502K in Q4 2013. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Prio Wealth Limited Partnership reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Prio Wealth Limited Partnership sold 2,646 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $238K.
Prio Wealth Limited Partnership first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 13 quarters.
Prio Wealth Limited Partnership's State Street SPDR S&P Biotech ETF position peaked at $502K in Q4 2013.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Prio Wealth Limited Partnership's 13F filing for Q2 2022, filed 27 Feb 2023.